InvestorsHub Logo
Followers 1324
Posts 66548
Boards Moderated 12
Alias Born 01/24/2010

Re: C C post# 15715

Tuesday, 03/24/2015 9:01:17 AM

Tuesday, March 24, 2015 9:01:17 AM

Post# of 16035
Compensated Awareness Post View Disclaimer
Looking for a BREAKOUT Nasdaq Stock for Tuesday? $VCEL

Manic Stock Alerts
We Are Looking at VCEL Verical Corp. Tomorrow and Looking at Her as a Swing Trade Not Just a Hit & Run Trading Idea.

This Baby Has Climbed Above her Weekly 50ma Resistance and This Chart Has Huge Upside Potential!


This Chart Has Been Waiting for a Catalyst and Think We Saw This with Last Nights Earnings Press Release!
Vericel ReportsTotal Revenues of $14.7 Million Reported for the Fourth Quarter


Could VCEL Be Setting Up to Head Towards 2012 Highs of Over 69.00 a Share??



VCEL - Vericel Corporation



Total Revenues of $14.7 Million Reported for the Fourth Quarter
Vericel Reports Fourth-Quarter and Year-End 2014 Financial Results

(See news below)
Read Full Article Here: http://finance.yahoo.com/news/vericel-reports-fourth-quarter-end-200100825.html

Company Overview

Website: http://www.vcel.com/

Developing Patient Specific Expanded Cellular Therapies


Vericel Corporation (formerly Aastrom Biosciences) is the leader in developing patient-specific expanded cellular therapies for use in the treatment of patients with severe diseases and conditions. The company markets two cell therapy products in the United States, Carticel® (autologous cultured chondrocytes), an autologous chondrocyte implant for the treatment of cartilage defects in the knee, and Epicel® (cultured epidermal autografts), a permanent skin replacement for the treatment of patients with deep dermal or full thickness burns comprising greater than or equal to 30% of total body surface area. Vericel is also developing MACI, a third-generation autologous chondrocyte implant for the treatment of cartilage defects in the knee, and ixmyelocel-T, a patient specific multicellular therapy for the treatment of advanced heart failure due to ischemic dilated cardiomyopathy (DCM).

Product Portfolio http://vcel.com/product-portfolio/



2 Year Weekly Chart





Financials & Filings
Visit: http://finance.yahoo.com/q/sec?s=VCEL+SEC+Filings to see complete details.







GlobeNewswire (Mon, Mar23)
Vericel Reports Fourth-Quarter and Year-End 2014 Financial Results
http://finance.yahoo.com/news/vericel-reports-fourth-quarter-end-200100825.html

GlobeNewswire (Wed, Mar 18)
Vericel to Present at Canaccord Genuity and ARM Investor Conferences
http://finance.yahoo.com/news/vericel-present-canaccord-genuity-arm-125149778.html

Zacks Small Cap Research (Thu, Feb 5)
Why Vericel Shares Will Double In 2015
http://finance.yahoo.com/news/vcel-why-vericel-shares-double-190000765.html

GlobeNewswire (Thu, Jan 29)
Vericel Completes Patient Enrollment in Phase 2b ixCELL-DCM Clinical Study of Ixmyelocel-T
http://finance.yahoo.com/news/vericel-completes-patient-enrollment-phase-134500845.html

Marketwired (Wed, Jan 7)
Vericel Corporation Names Three New Board Members
http://finance.yahoo.com/news/vericel-corporation-names-three-board-134500916.html



Contact



Vericel Corporation
64 Sidney Sreet
Cambridge, MA 02139
United States - Map
Phone: 617-252-7999
Fax: 617-252-7550
Website: http://www.aastrom.com



Join Us FREE http://trumpia.com/onlineSign…/ManicStockAlerts/ManicTraders

Super Fast Text Alerts!
TEXT "Manic" to 95577


Disclaimer
Manic Stock Alerts has not been compensated for VCEL
http://doiop.com/ManicDisclaimer

Follow Manic Stock Alerts!
http://goo.gl/F6Q54T



Hottest Big Board and Small Cap Board in Ihub
http://goo.gl/4NwuIA

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.